Similar articles

• A multinational study of thromboprophylaxis practice in critically ill children.

  Faustino EV, Hanson S, Spinella PC, Tucci M, O'Brien SH, Nunez AR, Yung M, Truemper E, Qin L, Li S, Marohn K, Randolph AG; PROphylaxis against ThRombosis prACTice (PROTRACT) Study Investigators of the PALISI BloodNet. Faustino EV, et al. Crit Care Med. 2014 May;42(5):1232-40. doi: 10.1097/CCM.0000000000000147. Crit Care Med. 2014. PMID: 24351371 Free PMC article.
• Time to recommend heparin and low-molecular-weight heparins in thromboprophylaxis in medical-surgical critically ill patients.

  Volpi N. Volpi N. Crit Care Med. 2013 Sep;41(9):2224-6. doi: 10.1097/CCM.0b013e31828fd852. Crit Care Med. 2013. PMID: 23979368 No abstract available.
• Is low-molecular-weight heparin useful for venovenous hemofiltration in the intensive care unit?

  Spiegel DM, Anderson RJ. Spiegel DM, et al. Crit Care Med. 1999 Oct;27(10):2316-7. doi: 10.1097/00003246-199910000-00056. Crit Care Med. 1999. PMID: 10548241 Review. No abstract available.
• DVT prevention. Low-molecular-weight heparin is a viable option.

  Benton L. Benton L. Am J Nurs. 2000 Feb;100(2):84. Am J Nurs. 2000. PMID: 10712165 No abstract available.
• Thromboprophylaxis in medical patients: the role of low-molecular-weight heparin.

  Turpie AG, Norris TM. Turpie AG, et al. Thromb Haemost. 2004 Jul;92(1):3-12. doi: 10.1160/TH03-07-0469. Thromb Haemost. 2004. PMID: 15213839 Review.